In May 2024, we entered into a partnership with Foundation Medicine, Inc. to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOne®CDx, as a companion diagnos…
PMV Pharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
PMVP-DEBT
Debt stack $293,000
90%
Market cache reports total debt of $293,000.
PMVP-DEBT-11844
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
PMV Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for PMV Pharmaceuticals, Inc..
PMV Pharmaceuticals, Inc. Ownership
Holder
Name
Confidence
Evidence
PMVP-OWNER-BML-CAPITAL-MANAGEMENT-LLC
BML Capital Management, LLC
90%
13F overlay lists BML Capital Management, LLC as top holder; 69 tracked holders.
PMV Pharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.